|premium|

EUR/USD Forecast: Upside break out of range? Vaccine hopes outweigh everything else

  • EUR/USD has been rising in response to optimism about a coronavirus vaccine. 
  • The lockdown-related slowdown and political uncertainty limit the upside move.
  • Monday's four-hour chart is showing a bullish bias and a well-defined range.

Is the light at the end of the tunnel becoming brighter? Investors received another shot in the arm, this time from AstraZeneca and the University of Oxford. The British immunization project reported efficacy of 70% on average – and 90% for a lower dose regiment. Injecting 1.5 doses instead of two proved more efficient. 

If the interim results are confirmed, it could mean being able to vaccinate more people. The European Union has a broad agreement with AstraZeneca and the doses only require a normal fridge temperature for storage. Monday's encouraging development joined earlier headlines of a joint G-20 commitment to hasten the deployment of vaccines.

Immunization could not come sooner. The winter wave of coronavirus has prompted governments to impose restrictions and these are taking their toll. Markit's preliminary Purchasing Managers' Indexes for November have all dropped, with services sectors contracting at a faster clip, weighing on the euro. France, which announced a stricter lockdown, is doing worse than Germany. 

Encouragingly, the EU seems to have turned a corner in stopping the spread of the virus, with the case curve bending lower. In the US, infections remain on the rise. 

Source: FT

Markit's US PMIs are also set to decline, yet remain in growth territory. However, the focus is on politics. President-elect Joe Biden is set to announce his picks for Treasury Secretary later in the week. Federal Reserve Governor Lael Brainard is reportedly in the lead for the post.

Outgoing President Donald Trump has been unsuccessful in his bid to overturn the election results, suffering blows in Georgia and Pennsylvania. Reuters has reported that Trump intends to slap new sanctions on Chinese companies, potentially boosting the safe-haven dollar. 

Overall, while there are several developments moving markets, vaccine optimism seems to have the upper hand. 

EUR/USD Technical Analysis

Euro/dollar is trading within a well-defined range between the double-bottom support at 1.1815 and 1.1895, a double-top. Both levels were last tested last week. The currency pair trades above the 50, 100, and 200 Simple Moving Averages, yet momentum and the Relative Strength Index are balanced. 

All in all, the bulls have a minor lead. Above 1.1895, the next lines to watch are 1.1920 and 1.2010.

Support awaits at 1.1850, which was a cushion late last week. Below 1.1815, the next level to watch is 1.1780.

More When the market shivers, the Fed delivers? Where next for markets

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Yohay Elam

Yohay Elam

FXStreet

Yohay is in Forex since 2008 when he founded Forex Crunch, a blog crafted in his free time that turned into a fully-fledged currency website later sold to Finixio.

More from Yohay Elam
Share:

Editor's Picks

EUR/USD: Bears retain control below 1.1780-1.1770 confluence breakpoint

The EUR/USD pair remains on the back foot through the Asian session on Friday and currently trades just above mid-1.1700s, well within striking distance of a nearly one-month low set the previous day.

GBP/USD seems vulnerable near one-month low vs. USD as traders await US data

The GBP/USD pair prolongs its weekly downtrend for the fifth consecutive day on Friday and slides back closer to a nearly one-month low, touched the previous day. Spot prices trade below mid-1.3400s during the Asian session on Friday and seem vulnerable to slide further as traders now look to important US macro data for a fresh impetus.

Gold eyes next breakout on US GDP, PCE inflation data

Gold sticks to recent gains around the $5,000-mark early Friday, biding time before the high-impact US macro events. The focus is now on the US fourth-quarter Gross Domestic Product, core Personal Consumption Expenditures Price Index and the Supreme Court’s ruling on President Donald Trump’s tariffs.

Bitcoin, Ethereum and Ripple remain range-bound as breakdown risks rise

Bitcoin, Ethereum, and Ripple are trading sideways within consolidation ranges on Friday, signaling a lack of directional bias in the broader crypto market. BTC rebounded from key support, and ETH is nearing the lower consolidation boundary, while XRP is holding at its lower trendline boundary. 

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.